BANNOCKBURN, Ill., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that the Company will release results for its fourth quarter

BANNOCKBURN, Ill. , April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31,

BANNOCKBURN, Ill. , April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31,

BANNOCKBURN, Ill. , April 07, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended

BANNOCKBURN, Ill. , April 15, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended

BANNOCKBURN, Ill. , April 16, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that it will release results for its first quarter ended March 31,

DENVER & BANNOCKBURN, Ill. --(BUSINESS WIRE)--Jan. 8, 2024-- Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services,

Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill. , May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc.

National leader in treating bleeding disorders offers personalized, high-quality patient care BANNOCKBURN, Ill. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. , the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been chosen by

First surgery-free treatment option for rare, difficult-to-treat urinary tract cancer requires complex clinical protocol BANNOCKBURN, Ill. , May 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent provider